116535-00-3

Upstream product

• 491-80-5 5,7-Dihydroxy-3-(4-methoxy-phenyl)-chromen-4-on 
• 100-39-0 benzyl bromide 

Downstream Products

• 68939-22-0 7-hydroxy-5-methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one 
• 67901-25-1 7-acetoxy-5,4'-dimethoxyisoflavone 
• 115101-99-0 7-benzyloxy-5-methoxy-3-(4-methoxy-phenyl)-chromen-4-one 
• 122764-21-0 5-acetoxy-7-benzyloxy-3-(4-methoxy-phenyl)-chromen-4-one 

Relevant academic research and scientific papers

Synthesis of potential prodrug systems for reductive activation. Prodrugs for anti-angiogenic isoflavones and VEGF receptor tyrosine kinase inhibitory oxindoles

A number of potential prodrug systems for reductive activation have been investigated. The prodrug systems chosen for the study were the 2-nitrophenylacetyl, 3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butanoyl and 4-nitrobenzyl groups, readily attached